- Title
- Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): A Phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload
- Creators
- Russell E Ware - St. Jude Children’s Research HospitalWilliam H Schultz - St. Jude Children’s Research HospitalNancy Yovetich - Rho, IncNicole A Mortier - St. Jude Children’s Research HospitalOfelia Alvarez - University of MiamiLee Hilliard - University of AlabamaRathi V Iyer - University of MississippiScott T Miller - SUNY-DownstateZora R Rogers - University of Texas SouthwesternJ. Paul Scott - Medical College of WisconsinMyron Waclawiw - National Heart Lung and Blood Institute, National Institutes of HealthRonald W Helms - Rho, Inc
- Publication Details
- Pediatric blood & cancer, Vol.57(6), pp.1011-1017
- Academic Unit
- Miller School of Medicine; UMMG Department of Pediatrics; UMMG Dept of Pediatrics - Hematology/Oncology/Stem Cell Transp
- Language
- English
- Resource Type
- Journal article
- PMID
- 21826782
- PMCID
- PMC3171640
- Record Identifier
- 991031576247002976
Journal article
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): A Phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload
Pediatric blood & cancer, Vol.57(6), pp.1011-1017
2011-12-01
PMCID: PMC3171640
PMID: 21826782
Metrics
9 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.225 Hematologic Diseases
- 1.225.626 Sickle Cell Disease
- Web Of Science research areas
- Hematology
- Oncology
- Pediatrics
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites